A decrease in maturity status (as determined by CD57%) was not anticipated to augment cytotoxic protein expression, as men with prostate cancer report CD56bright NK cells have substantially lower perforin MFI and CD57 expression compared to CD56dim (21). The gene discussed is PRF1; the disease is prostate carcinoma.